Lina Singleton

Lina Singleton, PharmD, RPh, currently serves as the Senior Director of Solid Tumors Scientific Communications at ImmunoGen, Inc. since October 2022. Previously, Lina held various leadership roles at Novartis Oncology, including Director of Strategy & Operations for U.S. Oncology Medical and Director of Scientific Communications from April 2020 to October 2022. Additional experience includes a Director position at Bristol-Myers Squibb, overseeing Medical Customer Engagement from July 2019 to April 2020, and a focus on Medical Information Digital Strategy at Novo Nordisk from November 2016 to July 2019. Lina's tenure at Bristol-Myers Squibb spanned from October 2009 to October 2016 in multiple roles linked to medical information and publications. Earlier pharmacy experience includes positions as a PRN Pharmacist at Walgreens Pharmacy and as a Pharmacy Intern at Publix Pharmacy. Lina earned a PharmD in Pharmacy from Florida Agricultural and Mechanical University, completing the degree in 2009.